journal1 ›› 2011, Vol. 19 ›› Issue (6): 521-523.

Previous Articles     Next Articles

Retrospective study of 1 066 cases in hyperphenylalaninemia in past 20 years

LI Xiao-wen1, WANG Lin2, SHEN Ming2, HE Chun3, ZHOU Zhong-shu2, WANG Kun-di2, YANG Ling2, YU Wei-min3   

  1. 1 Department of Nutrition;
    2 Department of Pediatrics;
    3 Department of China-Japan Friendship Institute, China-Japan Friendship Hospital, Beijing 100029, China
  • Received:2011-02-13 Online:2011-06-06 Published:2011-06-06

高苯丙氨酸血症1 066例随访分析

李晓雯1,王琳2,沈明2,贺春3,周忠蜀2,王琨蒂2,杨凌2,喻唯民3   

  1. 卫生部中日友好医院 1 营养科;
    2 儿科;
    3 临床医学研究所,北京 100029
  • 通讯作者: 沈明,E-mail:shenming26@msn.com
  • 作者简介:李晓雯(1964-),女,北京人,主管技师,本科学历,主要研究方向为临床营养,小儿遗传代谢病的营养治疗
  • 基金资助:
    国家自然科学基金(30271372)

Abstract: 【Objective】 To study on the prognosis of patients in hyperphenylalaminemia(HPA). 【Methods】 The neonatal screening, diagnosis and treatment starting time were considered in the follow-up study. The neuroimaging, MRI and 1HMRS were also performed in parts of these patients and the results were also considered as the index of prognosis. 【Results】 1)Of 1 066 patients 1 016 cases were diagnosed as phenylketonuria(PKU) and of which 50 cases were diagnosed as BH4D. Among the patients in PKU, 369(34.62%)were treated within 3 months after the neonatal screening, and 241(22.62%), 456(42.78%) were diagnosed and treated in 3~12 months and afterwards respectively. 2)The DQ of the patients who were treated within 3 months after the neonatal screening were much higher than that of non-screening patients(96±15,69±11;t=14.19,P<0.01). 3)The DQ of the patients who were treated later than 3 months were also highly improved after treatment(46±15 and 69±11,t=7.13,P<0.05). 4)There was a negative correlation between blood-brain Phe concentration to the mental retardation rblood=0.505, rbrain=0.647,P<0.01) in 22 cases of the HPA patients. 【Conclusion】 The long-term outcome of these patients benefits from early diagnosis and treatment, and the strict control of phe concentrations can minimize the mental retardation in HPA patients.

Key words: hyperphenylalaninemia, phenylketonuria, neonatal screening, dietary treatment

摘要: 【目的】 了解高苯丙氨酸血症(hyperphenylalaminemia, HPA)患者治疗随访及预后。 【方法】 对在本院诊断治疗的1 066例HPA的治疗随访结果进行回顾性分析。 【结果】 1)在1 066例HPA患儿中,共有1 016例为苯丙氨酸羟化酶缺乏症,即经典型苯丙酮尿症(phenylketonuria, PKU),50例为四氢生物蝶呤缺乏症(tetrahydrobiopterin deficiency, BH4D)。在这些PKU患者中,有369例(34.62%)患儿在新生儿筛查时被确诊并在3个月内开始规律治疗,241例(22.61%)在生后3~12个月内确诊, 456例(42.78%)在1岁后才确诊。2)3个月内筛查治疗的患儿智力发育明显高于非筛查确诊的患儿(96±15, 69±11;t=14.19,P<0.01﹚。3)3个月后才确诊的经治疗后智力水平也有明显提高﹙46±15,69±11,t=7.13,P<0.05﹚。4)氢质子磁共振波谱(1HMRS)检测22例HPA患儿的脑苯丙氨酸(phenylalanine, Phe)浓度表明患儿血、脑Phe浓度与智商均呈负相关关系(r=0.505,r=0.647,P<0.01)。 【结论】 对所有HPA患者均应进行鉴别诊断,尽早确诊和治疗, 控制血、脑苯丙氨酸浓度是减少智能落后的有效措施。

关键词: 高苯丙氨酸血症, 苯丙酮尿症, 新生儿筛查, 饮食治疗

CLC Number: